Timothy Cloughesy | Scholar Profiles and Rankings

Publications and Citation History

Publications based on Top Specialties

Types of Publication

Publications
Books
Patents
NIH/NSF

Add Delete
Digital “flipbooks” for enhanced visual assessment of simple and complex brain tumors (journal article) Cho, Nicholas S \| Le, Viên Lam \| Sanvito, Francesco \| Oshima, Sonoko \| Harper, Jayla \| Chun, Saewon \| Raymond, Catalina \| Lai, Albert \| Nghiemphu, Phioanh L \| Yao, Jingwen \| ... \| Ellingson, Benjamin M Neuro-Oncology (2024). 10.1093/neuonc/noae097 Cite \| Source
TLR agonists polarize interferon responses in conjunction with dendritic cell vaccination in malignant glioma: a randomized phase II Trial (journal article) Everson, Richard G. \| Hugo, Willy \| Sun, Lu \| Antonios, Joseph \| Lee, Alexander \| Ding, Lizhong \| Bu, Melissa \| Khattab, Sara \| Chavez, Carolina \| Billingslea-Yoon, Emma \| ... \| Prins, Robert M. Nature Communications, volume 15, issue 1 (2024). 10.1038/s41467-024-48073-y Cited by (1) \| Cite \| Source
Pseudo-Resting-State Functional MRI Derived from Dynamic Susceptibility Contrast Perfusion MRI Can Predict Cognitive Impairment in Glioma (journal article) Cho, Nicholas S. \| Wang, Chencai \| Van Dyk, Kathleen \| Sanvito, Francesco \| Oshima, Sonoko \| Yao, Jingwen \| Lai, Albert \| Salamon, Noriko \| Cloughesy, Timothy F. \| Nghiemphu, Phioanh L. \| Ellingson, Benjamin M. American Journal of Neuroradiology (2024). 10.3174/ajnr.A8327 Cite \| Source
ACTION: a randomized phase 3 study of ONC201 (dordaviprone) in patients with newly diagnosed H3 K27M-mutant diffuse glioma (journal article) Arrillaga-Romany, Isabel \| Lassman, Andrew \| McGovern, Susan L \| Mueller, Sabine \| Nabors, Burt \| van den Bent, Martin \| Vogelbaum, Michael A \| Allen, Joshua E \| Melemed, Allen S \| Tarapore, Rohinton S \| ... \| Cloughesy, Timothy Neuro-Oncology, volume 26, issue Supplement_2, pages S173-S181 (2024). 10.1093/neuonc/noae031 Cited by (1) \| Cite \| Source
Selective DRD2 antagonist and ClpP agonist ONC201 in a recurrent non-midline H3 K27M-mutant glioma cohort (journal article) Odia, Yazmin \| Hall, Matthew D \| Cloughesy, Timothy Francis \| Wen, Patrick Y \| Arrillaga-Romany, Isabel \| Daghistani, Doured \| Mehta, Minesh P \| Tarapore, Rohinton S \| Ramage, Samuel C \| Allen, Joshua E Neuro-Oncology, volume 26, issue Supplement_2, pages S165-S172 (2024). 10.1093/neuonc/noae021 Cited by (2) \| Cite \| Source
D-2-HG Inhibits IDH1mut Glioma Growth via FTO Inhibition and Resultant m6A Hypermethylation (journal article) Pianka, Sean T. \| Li, Tie \| Prins, Terry J. \| Eldred, Blaine S.C. \| Kevan, Bryan M. \| Liang, Haowen \| Zapanta Rinonos, Serendipity \| Kornblum, Harley I. \| Nathanson, David A. \| Pellegrini, Matteo \| ... \| Lai, Albert Cancer Research Communications, volume 4, issue 3, pages 876-894 (2024). 10.1158/2767-9764.CRC-23-0271 Cite \| Source
Quantification of T2-FLAIR Mismatch in Nonenhancing Diffuse Gliomas Using Digital Subtraction (journal article) Cho, Nicholas S. \| Sanvito, Francesco \| Le, Viên Lam \| Oshima, Sonoko \| Teraishi, Ashley \| Yao, Jingwen \| Telesca, Donatello \| Raymond, Catalina \| Pope, Whitney B. \| Nghiemphu, Phioanh L. \| ... \| Ellingson, Benjamin M. American Journal of Neuroradiology, volume 45, issue 2, pages 188-197 (2024). 10.3174/ajnr.A8094 Cited by (1) \| Cite \| Source
pH-Weighted amine chemical exchange saturation transfer echo planar imaging visualizes infiltrating glioblastoma cells (journal article) Patel, Kunal S \| Yao, Jingwen \| Cho, Nicholas S \| Sanvito, Francesco \| Tessema, Kaleab \| Alvarado, Alvaro \| Dudley, Lindsey \| Rodriguez, Fausto \| Everson, Richard \| Cloughesy, Timothy F \| ... \| Ellingson, Benjamin M Neuro-Oncology, volume 26, issue 1, pages 115-126 (2024). 10.1093/neuonc/noad150 Cited by (1) \| Cite \| Source
151 Exceptional Responders to Base Excision Repair (BER) Inhibition for Recurrent Glioblastoma Display Enrichment for DNA Damage Response Pathways: RNA Sequencing Analysis From a Multicenter Trial (journal article) Ozair, Ahmad \| Drappatz, Jan \| Ye, Xiaobu \| Berens, Michael \| Peng, Sen \| Rath, Sanhita \| Dhruv, Harshil \| Walbert, Tobias \| Holdhoff, Matthias \| Lesse, Glenn \| ... \| Ahluwalia, Manmeet Neurosurgery, volume 70, issue Supplement_1, pages 34-35 (2024). 10.1227/neu.0000000000002809_151 Cite \| Source
dCas9/CRISPR-based methylation of O-6-methylguanine-DNA methyltransferase enhances chemosensitivity to temozolomide in malignant glioma (journal article) Zapanta Rinonos, Serendipity \| Li, Tie \| Pianka, Sean Thomas \| Prins, Terry J. \| Eldred, Blaine S. C. \| Kevan, Bryan M. \| Liau, Linda M. \| Nghiemphu, Phioanh Leia \| Cloughesy, Timothy F. \| Lai, Albert Journal of Neuro-Oncology, volume 166, issue 1, pages 129-142 (2024). 10.1007/s11060-023-04531-z Cited by (1) \| Cite \| Source
Standardized brain tumor imaging protocols for clinical trials: current recommendations and tips for integration (journal article) Sanvito, Francesco \| Kaufmann, Timothy J. \| Cloughesy, Timothy F. \| Wen, Patrick Y. \| Ellingson, Benjamin M. Frontiers in Radiology, volume 3 (2023). 10.3389/fradi.2023.1267615 Cited by (1) \| Cite \| Source
NIMG-62. QUANTITATIVE ASSESSMENT OF T2-FLAIR MISMATCH IN HUMAN NON-ENHANCING GLIOMAS USING SUBTRACTION MAPS OF T2-W AND FLAIR MRI (journal article) Cho, Nicholas \| Sanvito, Francesco \| Le, Vien \| Oshima, Sonoko \| Teraishi, Ashley \| Yao, Jingwen \| Raymond, Catalina \| Pope, Whitney \| Nghiemphu, Phioanh \| Lai, Albert \| ... \| Ellingson, Benjamin Neuro-Oncology, volume 25, issue Supplement_5, pages v200-v200 (2023). 10.1093/neuonc/noad179.0758 Cite \| Source
TMET-12. CDKN2A DELETION REMODELS LIPID METABOLISM TO PRIME GLIOBLASTOMA FOR FERROPTOSIS (journal article) Minami, Jenna \| Morrow, Danielle \| Bayley, Nicholas \| Fernandez, Elizabeth \| Salinas, Jennifer \| Tse, Christopher \| Zhu, Henan \| Su, Baolong \| Sammarco, Alessandro \| Liau, Linda \| ... \| Nathanson, David Neuro-Oncology, volume 25, issue Supplement_5, pages v275-v275 (2023). 10.1093/neuonc/noad179.1056 Cited by (1) \| Cite \| Source
NIMG-50. TOTAL TUMOR CELLULARITY AND CELLULAR GROWTH RATES ESTIMATED USING A RADIO-PATHOMIC AI MODEL PREDICTS PROGNOSIS AND RESPONSE TO CYTOTOXIC THERAPY IN RECURRENT GBM (journal article) Oshima, Sonoko \| Yao, Jingwen \| Bobholz, Samuel \| Nagaraj, Raksha \| Raymond, Catalina \| Teraishi, Ashley \| Guenther, Anna-Marie \| Kim, Asher \| Sanvito, Francesco \| Cho, Nicholas \| ... \| Ellingson, Benjamin Neuro-Oncology, volume 25, issue Supplement_5, pages v197-v197 (2023). 10.1093/neuonc/noad179.0746 Cite \| Source
DNAR-05. EXCEPTIONAL RESPONDERS TO BASE EXCISION REPAIR (BER) INHIBITION FOR RECURRENT GLIOBLASTOMA DISPLAY ENRICHMENT FOR DNA DAMAGE RESPONSE PATHWAYS: RNA SEQUENCING ANALYSIS FROM A MULTICENTER TRIAL (journal article) Ozair, Ahmad \| Drappatz, Jan \| Ye, Xiaobu \| Berens, Michael \| Peng, Sen \| Rath, Sanhita \| Dhruv, Harshil \| Walbert, Tobias \| Holdhoff, Matthias \| Lesser, Glenn \| ... \| Ahluwalia, Manmeet Neuro-Oncology, volume 25, issue Supplement_5, pages v99-v99 (2023). 10.1093/neuonc/noad179.0371 Cite \| Source
IMMU-03. UTILIZING IN SILICO SINGLE-CELL TRANSCRIPTOMIC AND TCR PROFILING FOR THE IDENTIFICATION AND ISOLATION OF TUMOR-REACTIVE TCR CLONOTYPES IN RECURRENT GLIOBLASTOMA PATIENTS (journal article) Lee, Alexander \| Sun, Lu \| Chow, Frances \| Treger, Janet \| Cook, Danielle \| Porter, Ely \| Chen, Xi \| Herrera, Gilbert \| Everson, Richard \| Liau, Linda \| ... \| Prins, Robert Neuro-Oncology, volume 25, issue Supplement_5, pages v141-v141 (2023). 10.1093/neuonc/noad179.0535 Cite \| Source
IMMU-05. CD8 IMMUNOPET IMAGING IS ABLE TO MONITOR THE IMMUNE RESPONSE SENSITIVELY AND SPECIFICALLY IN GBM PATIENTS FOLLOWING NEOADJUVANT CHECKPOINT BLOCKADE IMMUNOTHERAPY (journal article) Prins, Robert \| Konik, Arda \| Sun, Lu \| Markus, Lauren \| Herrera, Gilbert \| Qin, Lei \| Everson, Richard \| Lee, Eudocia \| Reardon, David \| Shah, Hina \| ... \| Van den Abbeele, Annick D Neuro-Oncology, volume 25, issue Supplement_5, pages v142-v142 (2023). 10.1093/neuonc/noad179.0537 Cite \| Source
CSIG-04. INTEGRATED MOLECULAR AND FUNCTIONAL CHARACTERIZATION OF THE INTRINSIC APOPTOTIC MACHINERY IDENTIFIES A DIAGNOSTICALLY INFORMED THERAPEUTIC APPROACH FOR MALIGNANT GLIOMA (journal article) Fernandez, Elizabeth \| Mai, Wilson \| Song, Kai \| Bayley, Nicholas \| Kim, Jiyoon \| Zhu, Henan \| Liau, Linda \| Li, Gang \| Yong, William \| Souers, Andrew \| ... \| Nathanson, David Neuro-Oncology, volume 25, issue Supplement_5, pages v40-v40 (2023). 10.1093/neuonc/noad179.0160 Cite \| Source
CTIM-14. PHASE 1 SAFETY LEAD-IN AND RANDOMIZED OPEN-LABEL PERIOPERATIVE STUDY OF VORASIDENIB COMBINED WITH PEMBROLIZUMAB IN RECURRENT OR PROGRESSIVE ENHANCING IDH1-MUTANT ASTROCYTOMAS: SAFETY LEAD-IN RESULTS (journal article) Wen, Patrick \| Peters, Katherine \| de la Fuente, Macarena \| Mellinghoff, Ingo \| Arrillaga-Romany, Isabel \| Kumthekar, Priya \| Clarke, Jennifer \| Puduvalli, Vinay \| de Groot, John \| Zhang, Xiangmin \| ... \| Cloughesy, Timothy Neuro-Oncology, volume 25, issue Supplement_5, pages v64-v64 (2023). 10.1093/neuonc/noad179.0254 Cite \| Source
Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma (journal article) Friedman, Henry S. \| Prados, Michael D. \| Wen, Patrick Y. \| Mikkelsen, Tom \| Schiff, David \| Abrey, Lauren E. \| Yung, W.K. Alfred \| Paleologos, Nina \| Nicholas, Martin K. \| Jensen, Randy \| ... \| Cloughesy, Timothy Journal of Clinical Oncology, volume 41, issue 32, pages 4945-4952 (2023). 10.1200/JCO.22.02772 Cited by (5) \| Cite \| Source

Title	Investigators	Year	Cost	Agency
Career Enhancement Program	Cloughesy, Timothy	2020	$73,633	NATIONAL CANCER INSTITUTE
Career Enhancement Program	Cloughesy, Timothy	2019	$72,083	NATIONAL CANCER INSTITUTE
Career Enhancement Program	Cloughesy, Timothy	2018	$77,537	NATIONAL CANCER INSTITUTE
Career Enhancement Program	Cloughesy, Timothy	2017	$73,380	NATIONAL CANCER INSTITUTE
UCLA IRB 08-09-042: PHASE I TRIAL OF AFLIBERCEPT (VEGF TRAP) WITH RADIATION THE	Cloughesy, Timothy	2010	$9,888	NATIONAL CENTER FOR RESEARCH RESOURCES
UCLA IRB # 06-04-016 "PHASE II TRIAL OF BEVACIZUMAB IN COMBINATION WITH TEMOZ	Cloughesy, Timothy	2010	$141,075	NATIONAL CENTER FOR RESEARCH RESOURCES
UCLA IRB # 06-04-104 "A PHASE I/II, DUAL-CENTER, OPEN-LABEL TRIAL OF THE SAFE	Cloughesy, Timothy	2010	$27,029	NATIONAL CENTER FOR RESEARCH RESOURCES
PHASE I/II STUDY OF OSI-774 (ERLOTINIB) AND CCI-779 (TEMSIROLIMUS) IN PATIENT	Cloughesy, Timothy	2010	$659	NATIONAL CENTER FOR RESEARCH RESOURCES
PHASE II SINGLE ARM TRIAL OF VEGF TRAP IN PATIENTS WITH RECURRENT TEMOZOLOMIDE-	Cloughesy, Timothy	2009	$1,724	NATIONAL CENTER FOR RESEARCH RESOURCES
PHASE I/II STUDY OF OSI-774 (ERLOTINIB) AND CCI-779 (TEMSIROLIMUS) IN PATIENT	Cloughesy, Timothy	2009	$35,342	NATIONAL CENTER FOR RESEARCH RESOURCES
UCLA IRB #05-12-061 "A PHASE I STUDY OF VORINOSTAT (SUBEROYLANILIDE HYDROXAMI	Cloughesy, Timothy	2009	$2,155	NATIONAL CENTER FOR RESEARCH RESOURCES
UCLA IRB (PENDING) "A PHASE I/II STUDIES OF BAY 43-9006 (SORAFENIB) IN COMBIN	Cloughesy, Timothy	2009	$23,705	NATIONAL CENTER FOR RESEARCH RESOURCES
UCLA IRB # 06-04-104 "A PHASE I/II, DUAL-CENTER, OPEN-LABEL TRIAL OF THE SAFE	Cloughesy, Timothy	2009	$15,947	NATIONAL CENTER FOR RESEARCH RESOURCES
UCLA IRB # 06-04-016 "PHASE II TRIAL OF BEVACIZUMAB IN COMBINATION WITH TEMOZ	Cloughesy, Timothy	2009	$170,248	NATIONAL CENTER FOR RESEARCH RESOURCES
UCLA IRB # 06-04-016 "PHASE II TRIAL OF BEVACIZUMAB IN COMBINATION WITH TEMOZ	Cloughesy, Timothy	2008	$101,598	NATIONAL CENTER FOR RESEARCH RESOURCES
Consortium Therapeutic Studies of Primary Central Nervous System Malignancies	Cloughesy, Timothy	2008	$146,647	NATIONAL CANCER INSTITUTE
CLINICAL TRIAL: A PHASE II TRIAL OF POLY-ICLC IN PATIENTS WITH RECURRENT ANAPLAS	Cloughesy, Timothy	2008	$1,783	NATIONAL CENTER FOR RESEARCH RESOURCES
A BIOMARKER AND PHASE II STUDY OF GW 572016 IN RECURRENT MALIGNANT GLIOMA (NA	Cloughesy, Timothy	2008	$1,426	NATIONAL CENTER FOR RESEARCH RESOURCES
PHASE I/II STUDY OF OSI-774 (ERLOTINIB) AND CCI-779 (TEMSIROLIMUS) IN PATIENT	Cloughesy, Timothy	2008	$12,120	NATIONAL CENTER FOR RESEARCH RESOURCES
"A PHASE I/II STUDIES OF BAY 43-9006 (SORAFENIB) IN COMBIN	Cloughesy, Timothy	2008	$12,477	NATIONAL CENTER FOR RESEARCH RESOURCES
RECURRENT TEMOZOLOMIDE-RESISTANT MALIGNANT GLIOMAS	Cloughesy, Timothy	2008	$3,564	NATIONAL CENTER FOR RESEARCH RESOURCES
CONSORTIUM THERAPEUTIC STUDIES OF PRIMARY CENTRAL NERVI*	Cloughesy, Timothy	2008	$2,576	NATIONAL CENTER FOR RESEARCH RESOURCES
Consortium Therapeutic Studies of Primary Central Nervous System Malignancies	Cloughesy, Timothy	2007	$145,196	NATIONAL CANCER INSTITUTE
CONSORTIUM THERAPEUTIC STUDIES OF PRIMARY CENTRAL NERVI*	Cloughesy, Timothy	2007	$20,076	NATIONAL CENTER FOR RESEARCH RESOURCES
UCLA IRB # 06-04-016 "PHASE II TRIAL OF BEVACIZUMAB IN COMBINATION WITH TEMOZ	Cloughesy, Timothy	2007	$11,677	NATIONAL CENTER FOR RESEARCH RESOURCES
UCLA IRB (PENDING) "A PHASE I/II STUDIES OF BAY 43-9006 (SORAFENIB) IN COMBIN	Cloughesy, Timothy	2007	$5,495	NATIONAL CENTER FOR RESEARCH RESOURCES
UCLA IRB #05-12-061 "A PHASE I STUDY OF VORINOSTAT (SUBEROYLANILIDE HYDROXAMI	Cloughesy, Timothy	2007	$12,021	NATIONAL CENTER FOR RESEARCH RESOURCES
PHASE I/II STUDY OF OSI-774 (ERLOTINIB) AND CCI-779 (TEMSIROLIMUS) IN PATIENT	Cloughesy, Timothy	2007	$1,718	NATIONAL CENTER FOR RESEARCH RESOURCES
A BIOMARKER AND PHASE II STUDY OF GW 572016 IN RECURRENT MALIGNANT GLIOMA (NA	Cloughesy, Timothy	2007	$3,091	NATIONAL CENTER FOR RESEARCH RESOURCES
PHASE II TRIAL OF EMD 121974 FOR RECURRENT GLIOBLASTOMA: A CLINICAL TRIAL WIT	Cloughesy, Timothy	2007	$66,284	NATIONAL CENTER FOR RESEARCH RESOURCES
A PHASE II TRIAL OF POLY-ICLC IN PATIENTS WITH RECURRENT ANAPLASTIC GLIOMA N	Cloughesy, Timothy	2007	$6,182	NATIONAL CENTER FOR RESEARCH RESOURCES
A PHASE I/II TRIAL OF OSI-774 IN PATIENTS WITH RECURRENT MALIGNANT GLIOMAS AN	Cloughesy, Timothy	2006	$400	NATIONAL CENTER FOR RESEARCH RESOURCES
PHASE II TRIAL OF EMD 121974 FOR RECURRENT GLIOBLASTOMA: A CLINICAL TRIAL WIT	Cloughesy, Timothy	2006	$14,414	NATIONAL CENTER FOR RESEARCH RESOURCES
A MULTICENTER, OPEN-LABEL, RANDOMIZED, UNCONTROLLED, PHASE IIA TRIAL IN SUBJE	Cloughesy, Timothy	2006	$400	NATIONAL CENTER FOR RESEARCH RESOURCES
A PHASE II TRIAL OF POLY-ICLC IN PATIENTS WITH RECURRENT ANAPLASTIC GLIOMA N	Cloughesy, Timothy	2006	$86,483	NATIONAL CENTER FOR RESEARCH RESOURCES
A PHASE II TRIAL OF STI-571 ( NSC 716051) IN PATIENTS WITH RECURRENT MENINGIO	Cloughesy, Timothy	2006	$6,006	NATIONAL CENTER FOR RESEARCH RESOURCES
A MODIFIED PHASE I/II TRIAL OF RAPAMYCIN IN PATIENTS WITH MALIGNANT GLIOMAS	Cloughesy, Timothy	2006	$8,008	NATIONAL CENTER FOR RESEARCH RESOURCES
ZD1839 FOR TREATMENT OF RECURRENT OR PROGRESSIVE MALIGNANT ASTROCYTOMA OR GLI	Cloughesy, Timothy	2006	$801	NATIONAL CENTER FOR RESEARCH RESOURCES
CONSORTIUM THERAPEUTIC STUDIES OF PRIMARY CENTRAL NERVI*	Cloughesy, Timothy	2006	$5,078	NATIONAL CENTER FOR RESEARCH RESOURCES
Consortium Therapeutic Studies of Primary Central Nervi*	Cloughesy, Timothy	2006	$145,177	NATIONAL CANCER INSTITUTE
A MODIFIED PHASE I/II TRIAL OF RAPAMYCIN IN PATIENTS WITH MALIGNANT GLIOMAS	Cloughesy, Timothy	2005	$10,106	NATIONAL CENTER FOR RESEARCH RESOURCES
Consortium Therapeutic Studies of Primary Central Nervi*	Cloughesy, Timothy	2005	$143,873	NATIONAL CANCER INSTITUTE
CONSORTIUM THERAPEUTIC STUDIES OF PRIMARY CENTRAL NERVI*	Cloughesy, Timothy	2005	$9,831	NATIONAL CENTER FOR RESEARCH RESOURCES
PHASE I/II OF R115777 IN PATIENTS WITH RECURRENT MALIGNANT GLIOMAS	Cloughesy, Timothy	2005	$3,753	NATIONAL CENTER FOR RESEARCH RESOURCES
PHASE I-II TRIAL OF STI-571 (NSC 716051) IN PATIENTS WITH RECURRENT MALIGNANT	Cloughesy, Timothy	2005	$2,021	NATIONAL CENTER FOR RESEARCH RESOURCES
ZD1839 FOR TREATMENT OF RECURRENT OR PROGRESSIVE MALIGNANT ASTROCYTOMA OR GLI	Cloughesy, Timothy	2005	$3,753	NATIONAL CENTER FOR RESEARCH RESOURCES
A PHASE I/II TRIAL OF OSI-774 IN PATIENTS WITH RECURRENT MALIGNANT GLIOMAS AN	Cloughesy, Timothy	2005	$4,331	NATIONAL CENTER FOR RESEARCH RESOURCES
A PHASE II TRIAL OF STI-571 ( NSC 716051) IN PATIENTS WITH RECURRENT MENINGIO	Cloughesy, Timothy	2005	$4,909	NATIONAL CENTER FOR RESEARCH RESOURCES
PHASE II TRIAL OF POLY-ICLC FOR GLIOBLASTOMA [NABTC 01-05]	Cloughesy, Timothy	2005	$3,465	NATIONAL CENTER FOR RESEARCH RESOURCES
A PHASE II TRIAL OF POLY-ICLC IN PATIENTS WITH RECURRENT ANAPLASTIC GLIOMA N	Cloughesy, Timothy	2005	$92,974	NATIONAL CENTER FOR RESEARCH RESOURCES
Modified Phase I/II Trial of Rapamycin in Patients wit	Cloughesy, Timothy	2004	$8,459	NATIONAL CENTER FOR RESEARCH RESOURCES
Consortium Therapeutic Studies of CNS Malignancies	Cloughesy, Timothy	2004	$138,775	NATIONAL CANCER INSTITUTE
QUANTIFIED GENE EXPRESSION IMPROVES PROGNOSIS	Cloughesy, Timothy	2004	$27,525	NATIONAL CENTER FOR RESEARCH RESOURCES
Phase I/II of R115777 for Recurrent Malignant Gliomas	Cloughesy, Timothy	2004	$6,276	NATIONAL CENTER FOR RESEARCH RESOURCES
Phase II Evaluation of Fenretinide (NSC 374551) as a S	Cloughesy, Timothy	2004	$273	NATIONAL CENTER FOR RESEARCH RESOURCES
Phase I/II Trial of CCI-779 in Patients with Malignant Gliomas (NABTC 01-01)	Cloughesy, Timothy	2004	$6,821	NATIONAL CENTER FOR RESEARCH RESOURCES
ZD1839 for Treatment of Recurrent or Progressive Malignant Astrocytoma or Gli...	Cloughesy, Timothy	2004	$2,183	NATIONAL CENTER FOR RESEARCH RESOURCES
Phase I/II Trial of OSI-774 in Patients with Recurrent	Cloughesy, Timothy	2004	$19,646	NATIONAL CENTER FOR RESEARCH RESOURCES
GENE EXPRESSION PROGNOSIS &TRTMT RESPONSE STRATIFICATION IN PATS W/ GLIOMA	Cloughesy, Timothy	2002	$0	NATIONAL CENTER FOR RESEARCH RESOURCES
GENE EXPRESSION PROGNOSIS &TRTMT RESPONSE STRATIFICATION IN PATS W/ GLIOMA	Cloughesy, Timothy	2001	$0	NATIONAL CENTER FOR RESEARCH RESOURCES
GENE EXPRESSION PROGNOSIS &TRTMT RESPONSE STRATIFICATION IN PATS W/ GLIOMA	Cloughesy, Timothy	2001	$0	NATIONAL CENTER FOR RESEARCH RESOURCES
GENE EXPRESSION PROGNOSIS &TRTMT RESPONSE STRATIFICATION IN PATS W/ GLIOMA	Cloughesy, Timothy	2001	$48,533	NATIONAL CENTER FOR RESEARCH RESOURCES
PHASE I/II TRIAL OF IRONSTECAN IN PATIENTS WITH GLIOMA	Cloughesy, Timothy	2001	$0	NATIONAL CENTER FOR RESEARCH RESOURCES
PHASE 2 TRIAL OF THYMIDINE/CARBOPLATIN THERAPY OF GLIOMA	Cloughesy, Timothy	2001	$0	NATIONAL CENTER FOR RESEARCH RESOURCES
GENE EXPRESSION PROGNOSIS &TRTMT RESPONSE STRATIFICATION IN PATS W/ GLIOMA	Cloughesy, Timothy	2000	$61,492	NATIONAL CENTER FOR RESEARCH RESOURCES
GENE EXPRESSION PROGNOSIS &TRTMT RESPONSE STRATIFICATION IN PATS W/ GLIOMA	Cloughesy, Timothy	1999	$61,492	NATIONAL CENTER FOR RESEARCH RESOURCES
QUANTIFY GENE EXPRESSION: PROGNOSIS &THERAPY RESPONSE STRATIFICATION IN GLIOMA	Cloughesy, Timothy	1998	$12,684	NATIONAL CENTER FOR RESEARCH RESOURCES